Biological Models Volume Title: From Knowledge Networks to Biological Models

Biological Models Volume Title: From Knowledge Networks to Biological Models

Indexed in: Book Citation Index, Science Edition; BIOSIS Previews, EBSCO. Scopus.

Most findings about molecular interactions and cellular regulatory events are published in peer-reviewed scientific literature in the form of scientific jargon. The computerized text-mining ...
[view complete introduction]

US $
15

*(Excluding Mailing and Handling)



Development of Mechanistic Model for Drug-Induced Cholestasis and its Applications for Drug Development

Pp. 73-103 (31)

Nikolai Daraselia, Pat Morgan and Anton Yuryev

Abstract

We describe construction of mechanistic model for drug-induced cholestasis using information available from ResNet and ChemEffect knowledge networks in Pathway Studio software. We first developed the mechanistic model using information about protein targets of the cholestasis-inducing drugs. We then expanded the model by incorporating knowledge about protein functional annotation, protein homology, canonical pathways and pathway reconstruction. The expanded model provides a toxicity mechanism for 81% of the drugs known to induce cholestasis vs. 58% of the drugs explained by the original model. Using the model we suggest that FGF19 secreted proteins are the biomarker for drug-induced cholestasis. In this discussion we suggest how the mechanistic model can be used for predicting cholestasic risk for new compounds, how it can be used for development of biomarker panel to monitor cholestasis risk in patient during drug therapy, and how the model can be used in personalized medicine for evaluating patient predisposition for cholestasis.

Keywords:

Bioinformatics, cholestasis, CYP3A4, cytochrome p450, liver toxicity, toxicology, pathway analysis, bile acids, ABC transporters, biomarkers, mechanistic model, MDR1, drug metabolism, pathway studio.

Affiliation:

Ariadne Genomics Inc., Rockville, MD, USA